PCC 2.22% 22.0¢ probiomics limited

quarterly results, page-3

  1. 11,720 Posts.
    lightbulb Created with Sketch. 1695
    The quarterly took ages to appear on the asx site (after the pre-open period).

    Another shocking balance sheet. All the old 'supply problems', 'negotiated better royalties' blah... & still the receipts are pathetic. TC has been supporting this stock for years, meaning more dilution for the faithful.

    My guess is they are planning a Citrofish 'claim to cure cancer, ageing & impotence' type ann. That will give you, and all TC clients the opportunity to sell out.

    just imho, & good luck. I can imagine what you are going through.
 
watchlist Created with Sketch. Add PCC (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.